Dr. Disha Bharat Mehta, MD

Dr. Mehta practices at Dignity Health Medical Group Nevada in Henderson, Nevada.

Dr. Mehta's NPI, 1326488651, was assigned on July 1, 2013. Dr. Mehta holds Nevada license 18855.

Dr. Mehta's primary practice is Dignity Health Medical Group Nevada, at 2200 Paseo Verde Pkwy, Henderson, NV 89052 in Clark County. The practice phone is (702) 616-5865.

Dr. Mehta's primary practice is Dignity Health Medical Group Nevada in Henderson, Nevada. Dr. Mehta is also affiliated with Dignity Health - Saint Rose Dominican Hospital, San Martin Campus. The medical group on file is Dignity Health Medical Group Nevada. Dmand AI also links Dr. Mehta to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mehta is licensed in Nevada.

CMS data shows 125 Medicare services from Dr. Mehta across 4 procedure codes in 2024, for 76 Medicare patients. Medicare paid $10,959 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 65, with 55% women.

In 2024, Dr. Mehta wrote 156 Medicare Part D claims for 42 patients. 84% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $84 in total drug cost. In 2018, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 63 general payments to Dr. Mehta from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $705.